Market News

Forrester Research rated SELL: contract and client declines, AI competition, weak FCF and valuation concerns. Click here to read more about FORR.

Argus Research analyst Alexandra Yates maintains Intl Flavors & Fragrances (NYSE:IFF) with a Buy and raises the price target from $80 to $85.

The agreement covers the engineering, procurement, and construction scope for the simple cycle phase of Fermi's Siemens 6x1 combined cycle generat...

Argus Research analyst John Staszak maintains Darden Restaurants (NYSE:DRI) with a Buy and raises the price target from $240 to $245.

Morgan Stanley analyst Judah Frommer maintains Evommune (NYSE:EVMN) with a Overweight and lowers the price target from $55 to $26.

AVGO stock gains premarket. Jefferies reiterates Buy rating on Broadcom, pointing to massive long-term custom AI chip growth.

Health care stocks flashing warning to momentum investors. RSI indicator shows overbought for DFTX, NRIX, GALT. Check BZ Edge Rankings for more.

Whether it can or can't depends on one major factor.

Sable Offshore Corp. (NYSE:SOC) today announced its intention to offer, subject to market and other conditions, $100.0 million of common stock and $30...

Inuvo, Inc. (NYSE:INUV), a leader in artificial intelligence advertising technology, today announced financing transactions resulting in gross proceed...

PHINIA Inc. (NYSE: PHIN), a diversified, industrial supplier and global leader in the development of fuel systems, electrical systems, and aftermarket...

Comcast Corporation (NASDAQ:CMCSA) stock continued its upward momentum Tuesday following a major corporate restructuring plan to spin off NBCUniversal...

UBS analyst Peter Grom maintains Celsius Holdings (NASDAQ:CELH) with a Buy and lowers the price target from $55 to $50.

Wedbush analyst David Nierengarten maintains Abivax (NASDAQ:ABVX) with a Neutral and raises the price target from $90 to $110.

SpaceKnow joins a select group of early partners in Satellogic's emerging agentic intelligence ecosystem, built on its Persistent Global Intellige...

https://www.reuters.com/legal/litigation/us-working-ban-targeting-chinese-energy-inverters-sources-say-2026-06-30/

Canaccord Genuity analyst Joseph Vafi maintains Strategy (NASDAQ:MSTR) with a Buy and lowers the price target from $163 to $130.

Wall Street analysts changed outlook on top names, including Alphine Income Property Trust, AAR Corp, and Evommune. See analyst ratings for these stoc...

Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Neutral and raises the price target from $6 to $9.

Marathon Petroleum (MPC) shows explosive 787.5% EPS growth and strong analyst revisions with a high HGM rating of 6. Its technical setup (TA 8, Setup ...